Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation

@article{Bai2015SulforaphanePA,
  title={Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation},
  author={Yang Bai and Xiaolu Wang and Song Zhao and Chun-ye Ma and Jiuwei Cui and Yang Zheng},
  journal={Oxidative Medicine and Cellular Longevity},
  year={2015},
  volume={2015},
  url={https://api.semanticscholar.org/CorpusID:979207}
}
The evidence from clinical studies and animal experiments relating to the potential mechanisms by which SFN modulates Nrf2 activation and protects against CVD are summarized.
[PDF] Semantic Reader
161 Citations
Highly Influential Citations
4
Background Citations
53
Methods Citations
2
Results Citations
1

Figures from this paper

Ask This Paper
BETA
AI-Powered

Our system tries to constrain to information found in this paper. Results quality may vary. Learn more about how we generate these answers.

161 Citations

Concerted redox modulation by sulforaphane alleviates diabetes and cardiometabolic syndrome.

A review on herbal Nrf2 activators with preclinical evidence in cardiovascular diseases

The activation of Nrf2 pathway is highlighted as a budding therapeutic option for the prevention and treatment of CVDs, which needs further investigation and validation in the clinical settings.

Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure

Systemic activation of Nrf2 and antioxidant protein signaling by bardoxolone methyl may have beneficial effects on cardiac function and result in improvements by enhancing antioxidant enzyme expression and attenuating myocardial inflammation.

The Role of Natural Products in Targeting Cardiovascular Diseases via Nrf2 Pathway: Novel Molecular Mechanisms and Therapeutic Approaches

The beneficial effects of using natural bioactive compounds as a promising therapeutic approach for the prevention and treatment of CVDs are reviewed.

Nrf2 at the heart of oxidative stress and cardiac protection.

Multiple lines of evidence presented here support the potential of dialing up the Nrf2 pathway for cardiac protection in the clinic, including removal of Keap1 by autophagy due to p62/SQSTM1 binding, inhibition of βTrCP or Synoviolin/Hrd1-mediated ubiquitination of NRF2, and de novo Nrf1 protein translation.

Sulforaphane induces neurovascular protection against a systemic inflammatory challenge via both Nrf2-dependent and independent pathways.

Sulforaphane: a nutraceutical against diabetes-related complications.

Effects of sulforaphane on the oxidative response, apoptosis, and the transcriptional profile of human stomach mucosa cells in vitro.

Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease

A review of the literature on Nrf2/HO-1 and its role in metabolic disease syndrome and CVD provides an overview of the literature on Nrf2/HO-1 and its role in metabolic disease syndrome and CVD.

Sulforaphane—A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies

SFN’s ability to activate Nrf2, a transcription factor regulating oxidative stress and inflammation in cells, is a primary mechanism behind its anticancerogenic and antidiabetic effects and its antioxidant, anti-inflammatory, and anti-apoptotic properties are suggested to provide beneficial effects against neurodegenerative diseases.
...

91 References

Modulation of phase II enzymes by sulforaphane: implications for its cardioprotective potential.

The potential cardioprotective action of sulforaphane was confirmed by the decrease in intracellular reactive oxygen species production, the increase in cell viability, and the decreases in DNA fragmentation after long-term treatment accompanied by the induction of antioxidants and phase II enzymes in cardiomyocytes.

Protective effect of sulforaphane against oxidative stress: recent advances.

Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane.

Results from these clinical trials indicate that interventions with well characterized preparations of broccoli sprouts may enhance the detoxication of aflatoxins and air-borne toxins, which may in turn attenuate their associated health risks, including cancer, in exposed individuals.

Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants

It is suggested that diabetes-induced aortic fibrosis, inflammation, and oxidative damage can be prevented by SFN and the aortIC protection from diabetes bySFN was associated with the up-regulation of Nrf2 and its downstream antioxidants.

The emerging role of redox-sensitive Nrf2-Keap1 pathway in diabetes.

The pathological roles of environmental and redox stresses in cardiovascular diseases

This review focuses on the pathological roles of environmental and redox stresses in cardiovascular diseases, especially severe cardiac dysfunction and the transition from compensated hypertrophy to heart failure.

Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage

Translational studies of A20 in atherosclerosis and cardiovascular disease.

The role of the NF- kappaB-regulated, yet potent NF-kappaB inhibitory and anti-inflammatory gene A20/TNFAIP3 in atherogenesis is reviewed, and the potential use of its atheroprotective properties for the prevention and treatment of cardiovascular diseases is highlighted.

Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes.

Evidence that sulforaphane is effective in reversing the various deficits in experimental diabetic neuropathy is provided and the defensive role of Nrf2 in neurons under conditions of oxidative stress is supported and suggests that the NF-κB pathway is an important modulator of inflammatory damage in diabetic neuroopathy.

Nrf2 as a target for cancer chemoprevention.

...